Kathleen S. Wright Associates Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Kathleen S. Wright Associates Inc.
- $242 Million
- Q4 2024
A detailed history of Kathleen S. Wright Associates Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Kathleen S. Wright Associates Inc. holds 90 shares of REGN stock, worth $65,112. This represents 0.03% of its overall portfolio holdings.
Number of Shares
90
Previous 90
-0.0%
Holding current value
$65,112
Previous $94,000
31.91%
% of portfolio
0.03%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,488Shares Held
85.7MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.72 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.11 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$5.11 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.5 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.43 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $77.5B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...